机译:Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trial
Cedars Sinai Samuel Oschin Canc Ctr, Los Angeles, CA 90048 USA;
Canc Res & Biostat, Seattle, WA USA;
Michigan State Univ, Spectrum Hlth Canc Ctr, Grand Rapids, MI USAMayo Clin, Rochester, MN USAUniv Arkansas Med Sci, Myeloma Inst, Little Rock, AR 72205 USASanford NCORP Northern Cent Plains, Siouxland Reg Canc Ctr, Sioux City, IA USASoutheast Clin Oncol Res Consortium NCORP, Canc Care Western North Carolina, Asheville, NC USACleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USASt Joseph Mercy Hosp, Michigan Canc Res Consortium NCORP, Ann Arbor, MI 48104 USAUniv Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USAMt Sinai Sch Med, Myeloma Program, New York, NY USAMayo Clin, Div Hematol, Rochester, MI USA;